Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Equizym MCA
- Development stage
- Unknown
- Lead developer
- Kyberg Pharma
- Modality
- Recombinant Proteins and Enzymes, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Equizym MCA is an oral multi-ingredient dietary supplement manufactured by Kyberg Pharma. It is formulated as tablets containing a combination of plant-derived proteolytic enzymes (bromelain from pineapple and papain from papaya), a patented protein-rich lentil extract (Defensan®), selenium (as sodium selenite), and Vitamin B2 (riboflavin). Equizym MCA is used as a supportive or complementary nutritional supplement during and after chemotherapy, radiation therapy, or adjuvant hormone therapy (such as in breast cancer patients) to help compensate for nutritional deficiencies, support mucous membrane function, boost immune defense, and alleviate side effects like arthralgia and mucosal dryness.
- Brand names
- Equizym MCA
- Other names
- EquizymEquizym® MCAbromelain + papain + Lens culinaris lectin + riboflavin + sodium selenitebromelain + papain + lentil extract + riboflavin + sodium selenite
Beyond the preview
Go deeper on Equizym MCA.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Equizym MCA.